Stem Cells Archives | Page 92 of 201

Horizon 2020 consortium funding to fuel cell therapy microcarrier development at denovoMATRIX

April 29, 2021 By Cade Hildreth, Founder & President Leave a Comment

DRESDEN, Germany, April 29, 2021 — denovoMATRIX GmbH, a developer of technologies which enable high quality stem cell expansion, announced today that it will participate in the new European collaborative project funded by the European Union’s Horizon 2020 research and innovation program.

World first: TreeFrog Therapeutics announces the production of a single batch of 15 billion iPS cells in a 10L bioreactor with exponential amplification of 276-fold per week

April 15, 2021 By Cade Hildreth, Founder & President Leave a Comment

Biomimetic 3D cell culture technology unlocks the manufacturing bottleneck of stem-cell derived cell therapies through exponential hiPSC growth in large-scale bioreactors, with best-in-class cell quality.

Bordeaux, France – April 13^th, 2021. French cell therapy company TreeFrog Therapeutics announces unprecedented exponential growth of human induced pluripotent stem cells (hiPSC) in a 10L bioreactor[1]. Using proprietary C-Stem^TM technology, TreeFrog Therapeutics amplified 50 million hiPSC into a single batch of 15 billion cells in 6.5 days, and company reports exceptional cell quality. Data will be presented at the International Society for Stem Cell Research (ISSCR) Virtual Meeting, taking place June 21 – 26, 2021. [Read more…]

Shoreline Biosciences Raises $43M to Advance iPSC-derived Cellular Immunotherapies

April 14, 2021 By Cade Hildreth, Founder & President Leave a Comment

Shoreline Biosciences, a California-based start-up specializing in iPSC-derived cellular immunotherapies for cancer and other serious diseases, announced it has completed an impressive $43M funding round. Founded in 2020 in La Jolla, CA, the company is developing a pipeline of induced pluripotent stem cell (iPSC) derived NK cell and macrophage cell therapy product candidates. The company joins an impressive list of pioneers who are now forging the path toward iPSC-derived cell therapeutics. [Read more…]

5 Reasons to Use Biological Industries’ NutriStem® for Isolation and Growth of hMSCs

April 6, 2021 By Cade Hildreth, Founder & President Leave a Comment

Human mesenchymal stem cells (hMSCs) are multipotent adult stem cells present in a variety of tissue niches within the human body. As multipotent cells, they can differentiate into a range of cell types, including osteoblasts, chondrocytes, myocytes, and adipocytes. In addition to secreting factors that can stimulate tissue repair, MSCs can substantially alter their microenvironment, exerting effects that are both anti-inflammatory and anti-fibrotic. [Read more…]

Cytonome cell sorter aids in Parkinson’s treatment

April 6, 2021 By Cade Hildreth, Founder & President Leave a Comment

April 6, 2021, BEDFORD, Mass. — Cell sorting technology leader and innovator Cytonome-ST, LLC, has assisted pharmaceutical firm Sumitomo Dainippon Pharma Co., Ltd. to produce enough human stem cells to proceed with a clinical trial of a new treatment aimed at curing Parkinson’s Disease. [Read more…]